Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
2(50.0%)
4Total
N/A(2)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT02814929Completed

Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey

Role: collaborator

NCT04064801Completed

Red Cell Distribution Width as a Predictor of Mortality in Acute Methanol Poisoning

Role: lead

NCT04397081Completed

Atopic Diseases & Human Papilloma Virus

Role: lead

NCT03124524Phase 4Completed

Treatment Choice in Primary Dysmenorrhea

Role: lead

NCT03127293Completed

Hyperemesis Gravidarum and Osteoporosis

Role: lead

NCT02980770Unknown

Postoperative Complications in Patients With Obesity Hypoventilation Syndrome

Role: collaborator

NCT02287935Not ApplicableCompleted

Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease

Role: lead

NCT01745315Not ApplicableUnknown

Comparison of Perioperative Outcomes of Three Different Instruments in Total Laparoscopic Hysterectomy

Role: lead

NCT01423838Phase 4Unknown

Comparison of Solifenacin and Oxybutynin in the Treatment of Overactive Bladder

Role: lead

All 9 trials loaded